Thought Leadership | Fish & Richardson

Diversity, Equity & Inclusion

Pro Bono & Social Responsibility

Legal Operations

Legal Project Management

Knowledge Management

Legal Technology Services

Patent Litigation

Trademark, Copyright & Media Litigation

Trade Secret Litigation

Standard Essential Patents

Chancery & Corporate Governance

<p><em>Inter Partes </em>Review</p>

Post-Grant Review

<p><em>Ex Parte</em> Reexamination</p>

Supplemental Examination

Patent Prosecution

Strategic Patent Counseling & Opinions

Patent Portfolio Management

Unitary Patent & Unified Patent Court

IP Licensing, Transactions & Agreements

Trademark & Copyright Counseling & Prosecution

Strategic Counseling, Registration & Opinions

Advertising & Marketing

Domain Names & Internet

TTAB Oppositions & Cancellations

Digital Millennium Copyright Act

Transactions & Agreements

Regulatory & Government Affairs

Communications & Spectrum Regulation

Drug & Medical Device Regulation

mHealth & Telemedicine

Privacy & Data Security

Electrical & Computer Technology

Software & Internet

Consumer Electronics

Artificial Intelligence

Digital Media & E-Commerce

Financial, Business & FinTech Services

Telecommunications

Energy & Chemicals

Biotech & Diagnostics

Medical Devices

Pharmaceuticals

Academic Research & Medical Centers

Transportation, Aerospace & Defense

Autonomous Vehicles

Thought Leadership

IP Law Essentials

Post-Grant Annual Reports

Search results

Blog | December 23, 2014

Digital Health and the Alice Decision

Blog | December 10, 2014

ITC — Recent Commission Opinion Emphasizes Need To Show A "Nexus" Between Patent Claims and An R&D Based Domestic Industry

Blog | December 03, 2014

ITC's Authority to Enforce Consent Orders Extends to Importations by Third Parties

Blog | December 03, 2014

Infringement Suit Must Target United States Where Private Entity is Legally Required to Perform Quasi-Governmental Functions

Blog | December 03, 2014

Challenge of PTAB's Authority at the District Court Amounts to Impermissible Collateral Attack

Article | November 05, 2014

The Patent Use Code Conundrum — or Why FDA Can't Read (Patents)

Blog | November 05, 2014

Damages base - is the name of the game the claim?

Article | October 24, 2014

Government Heeds Fish's Admonition

Blog | October 20, 2014

A Single "e.g." Phrase, As Opposed To An "i.e." Phrase, Failed To Save Facially Subjective Claim Term From Indefiniteness

Blog | October 14, 2014

Reputation of defendant and its products not relevant to analytical method

Blog | October 08, 2014

EDTX rejects arguments that expert should have included sunk costs and did not apportion

Blog | September 19, 2014

Drug Labels Can Provide The "Specific Intent" Required For Inducement Of Infringement